Biotech stocks have been overlooked for the past year and a half, says Jefferies’ Michael Yee

CNBC Television published this video item, entitled “Biotech stocks have been overlooked for the past year and a half, says Jefferies’ Michael Yee” – below is their description.

Michael Yee, Jefferies managing director, joins ‘Power Lunch’ to break down Moderna’s quarterly earnings results, which companies in the biotech space are ‘recession-proof’ and near-term headline risk with the reconciliation bill making its way through Congress.

For access to live and exclusive video from CNBC subscribe to CNBC PRO:

» Subscribe to CNBC TV:

» Subscribe to CNBC:

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30:

Connect with CNBC News Online

Get the latest news:

Follow CNBC on LinkedIn:

Follow CNBC News on Facebook:

Follow CNBC News on Twitter:

Follow CNBC News on Instagram:



CNBC Television YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.

About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

Texas bonds offer good yields, great opportunity, says Neuberger’s James Iselin

Final Trades: Salesforce, Volkswagen, Booz Allen & more

Inside Credit Suisse’s bearish call on commodities

In This Story: Moderna

Moderna is an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies based exclusively on messenger RNA.

CEO: Stéphane Bancel (2011–)

Stock ticker: (NASDAQ:MRNA)

5 Recent Items: Moderna

You should probably keep owning Moderna or buy some, says Oppenheimer analyst

Moderna stock drops amid President Biden’s signaling an end to COVID pandemic

COVID-19: BC provides update on fall booster campaign | LIVE

Moderna, Pfizer Begin Omicron Booster Roll Out

CDC Panel Recommends Pfizer’s And Moderna’s New Covid Booster Shots

In This Story: Podcast

A podcast is an episodic series of digital audio files that a user can download to a personal device for easy listening.

3 Recent Items: Podcast

On the ground in Kharkiv | Ukraine: The Latest | Podcast

Companies selling digital subscriptions have to do business another way, says Lazard’s Dennis Berman

Cobra Kai Cast Test Karate Gadgets | WIRED

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.